GSA Capital Partners’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-125,334
Closed -$40K 2053
2023
Q1
$40K Sell
125,334
-321,277
-72% -$168K ﹤0.01% 1410
2022
Q4
$188K Buy
446,611
+266,897
+149% +$269K 0.02% 1202
2022
Q3
$175K Buy
179,714
+161,536
+889% +$285K 0.02% 1267
2022
Q2
$53K Sell
18,178
-52,895
-74% -$222K 0.01% 1281
2022
Q1
$534K Buy
71,073
+6,920
+11% +$57.3K 0.07% 481
2021
Q4
$897K Buy
64,153
+15,051
+31% +$297K 0.11% 253
2021
Q3
$1.27M Buy
+49,102
New +$1.56M 0.13% 192

Other funds holding AMTI

GSA Capital Partners's AMTI Position: Q2 2023 in Review

GSA Capital Partners sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2023, closing a stake of 125,334 shares — an estimated $40K sold.

GSA Capital Partners first reported a position in AMTI in Q3 2021 and held it in 7 quarters. The position peaked at $1.27M in Q3 2021. 28 funds tracked by Wall St. Rank hold AMTI as of Q2 2023.

  • GSA Capital Partners reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • GSA Capital Partners sold 125,334 Applied Molecular Transport Inc. Common Stock shares in Q2 2023, an estimated $40K.
  • GSA Capital Partners first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • GSA Capital Partners's Applied Molecular Transport Inc. Common Stock position peaked at $1.27M in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2023.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.